TrimTabs Asset Management »

Ptc Therapeutics I shares owned by TrimTabs Asset Management

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by TrimTabs Asset Management from 13F filings

Historical chart of TrimTabs Asset Management investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by TrimTabs Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by TrimTabs Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.8M 76k 75.96

More positions owned by TrimTabs Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
MasterCard Incorporated (MA)
Abbvie (ABBV)
Applovin Corp Class A (APP)
Bristol Myers Squibb (BMY)
Amgen (AMGN)
Tapestry (TPR)
Colgate-Palmolive Company (CL)
Broadcom (AVGO)
Lam Research (LRCX)
Gilead Sciences (GILD)
Arista Networks (ANET)
Vertiv Holdings Llc vertiv holdings (VRT)
Hilton Worldwide Holdings (HLT)

View all positions for TrimTabs Asset Management

Top funds holding Ptc Therapeutics I

Vanguard Group
Rtw Investments
BlackRock
Wellington Management Company
State Street Corporation
Henderson Group
Armistice Capital
Toronto-Dominion Bank
D. E. Shaw & Co
Geode Capital Management
Citadel Advisors
Leucadia National Corporation
FMR
Tang Capital Management
Franklin Resources

View all funds holding Ptc Therapeutics I